Maintenance fees coming due
6 maintenance fees come due in the 12 months from Nov 14, 2026, the next on Dec 18, 2026. Unpaid by Jun 21, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 10,322,411 | Systems for Microfluidic Logic Devices In force Fee due Dec 18, 2026 Lapses if unpaid Jun 21, 2027 · High confidence | Standard Biotools Inc. | In force | Dec 18, 2026 | Jun 21, 2027 | High confidence | |
| US 11,776,801 | Inductively Coupled Plasma Based Atomic Analysis Systems and Methods In force Fee due Apr 3, 2027 Lapses if unpaid Oct 4, 2027 · High confidence | Standard Biotools Canada Inc. | In force | Apr 3, 2027 | Oct 4, 2027 | High confidence | |
| US 9,163,053 | Nucleotide Analogs In force Fee due Apr 20, 2027 Lapses if unpaid Oct 20, 2027 · Low confidence | Standard Biotools Inc. | In force | Apr 20, 2027 | Oct 20, 2027 | Low confidence | |
| US 10,578,633 | Methods and Devices for Analysis of Defined Multicellular Combinations In force Fee due Sep 3, 2027 Lapses if unpaid Mar 3, 2028 · High confidence | Standard Biotools Inc. | In force | Sep 3, 2027 | Mar 3, 2028 | High confidence | |
| US 9,304,065 | Methods, Systems and Devices for Multiple Single-Cell Capturing and Processing Using Microfluidics In force Fee due Oct 5, 2027 Lapses if unpaid Apr 5, 2028 · High confidence | Standard Biotools Inc. | In force | Oct 5, 2027 | Apr 5, 2028 | High confidence | |
| US 9,316,331 | Multilevel Microfluidic Systems and Methods In force Fee due Oct 19, 2027 Lapses if unpaid Apr 19, 2028 · High confidence | Standard Biotools Inc. | In force | Oct 19, 2027 | Apr 19, 2028 | High confidence |
6 of 6 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.